Coccidioides Posadasii Dna
Generic Name: coccidioides posadasii dna
Dosage form: LIQUID. Active ingredients: COCCIDIOIDES POSADASII DNA (30 [hp_X]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: COCCIDIOIDES POSADASII DNA (30 [hp_X]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Azelastine Hydrochloride Ophthalmic Solution 0.05%
azelastine hydrochloride ophthalmic solution 0.05%
DESCRIPTION Azelastine hydrochloride ophthalmic solution, USP 0.05% is a sterile ophthalmic solution containing azelastine hydrochloride, a relatively selective H 1 -receptor antagonist for topical administration to the eyes. Azelastine hydrochloride is a white crystalline powder with a molecular weight of 418.37. Azelastine hydrochloride is sparingly soluble in water, methanol and propylene glycol, and slightly soluble in ethanol, octanol, and glycerine.
Buprenorphine Hydrochloride And Naloxone Hydrochloride
buprenorphine hydrochloride and naloxone hydrochloride
11 DESCRIPTION ZUBSOLV (buprenorphine and naloxone) sublingual tablets are white menthol-flavored tablets in an oval shape for the dosage strength 0.7 mg/0.18 mg, a triangular shape for the dosage strength 1.4 mg /0.36 mg, a D shape for the dosage strength 2.9 mg/0.71 mg, a round shape for the dosage strength 5.7 mg/1.4 mg, a diamond shape for the dosage strength 8.6 mg/2.1 mg and a capsule shape for the dosage strength 11.4 mg/2.9 mg.
Micafungin Sodium
micafungin sodium
11 DESCRIPTION Micafungin for injection, USP is a sterile, lyophilized product for intravenous (IV) infusion that contains micafungin sodium. Micafungin sodium is a semisynthetic lipopeptide (echinocandin) synthesized by a chemical modification of a fermentation product of Coleophoma empetri F-11899. Micafungin inhibits the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.